Drug Type Prophylactic vaccine, Fusion protein |
Synonyms- |
Target |
Mechanism SARS-CoV-2 antigen inhibitors, Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Dec 2023), |
RegulationEmergency Use Authorization (CN) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
COVID-19 | CN | 01 Dec 2023 |